Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.0150 (2.71%) ($7.0150 - $7.0150) on Fri. Oct. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.35% (three month average) | RSI | 51 | Latest Price | $7.0150(2.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(78%) XBI(77%) IBB(66%) IBUY(65%) ARKK(64%) | Factors Impacting EDIT price | EDIT will decline at least -1.675% in a week (0% probabilities). TBT(-23%) VXX(-20%) VIXM(-16%) UUP(-14%) EDOC(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.675% (StdDev 3.35%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.93(-170.28%) | Resistance Level | $7.33 | 5 Day Moving Average | $7.07(-0.78%) | 10 Day Moving Average | $7.11(-1.34%) | 20 Day Moving Average | $7.33(-4.3%) | To recent high | -24.4% | To recent low | 2.7% | Market Cap | $436m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |